Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSainsbury's Regulatory News (SBRY)

Share Price Information for Sainsbury's (SBRY)

Share Price is delayed by 15 minutes
Get Live Data
304.60    8.30 (2.80%)
Bid:
303.70
Ask:
303.90
Spread: 0.20 (0.066%)
Market Cap: £6.75b
SBRY Live PriceLast checked at - London Stock Exchange

Intraday Sainsbury's Share Chart

EMTN Programme Supplementary Prospectus

1 Jul 2025 12:55

RNS Number : 2446P
Sainsbury(J) PLC
01 July 2025
 

1 July 2025

 

EMTN PROGRAMME PUBLICATION OF SUPPLEMENTARY PROSPECTUS

J Sainsbury plc

(the "Company")

 

The following supplementary prospectus has been approved by the Financial Conduct Authority and is available for viewing:

 

The supplementary prospectus dated 1 July 2025 (the "Supplementary Prospectus") supplementing the base prospectus (the "Prospectus") dated 17 January 2025 relating to the establishment of the £5,000,000,000 Euro Medium Term Note Programme, with J Sainsbury plc as the issuer.

 

The Supplementary Prospectus incorporates by reference the audited financial statements of the Company for the 52-week period ended on 1 March 2025.

 

The Supplementary Prospectus should be read and construed in conjunction with the Prospectus.

 

The full document can be viewed at: http://www.rns-pdf.londonstockexchange.com/rns/2446P_1-2025-7-1.pdf

 

A copy of the Prospectus has been submitted to the Financial Conduct Authority's Electronic Submission Service and may shortly be viewed on the National Storage Mechanism (NSM) at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

J Sainsbury plc LEI Number: 213800VGZAAJIKJ9Y484

 

Enquiries

Investor Relations Media

James Collins Rebecca Reilly

 +44 (0) 7801 813 074 +44 (0) 20 7695 7295

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. The Prospectus is not intended for use in the United States and is not addressed or targeted at U.S. persons and should not be relied upon by any U.S. person. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirement. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PSPFFLFBEDLZBBX
Date   Source Headline
23rd Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSCommencement of Share Buyback Programme
17th Apr 20257:00 amRNSFinal Results
11th Apr 20252:00 pmRNSDirector/PDMR Shareholding
11th Apr 202510:00 amRNSHolding(s) in Company
7th Apr 202510:00 amRNSHolding(s) in Company
4th Apr 202511:00 amRNSHolding(s) in Company
3rd Apr 20257:00 amRNSDirectorate Change
1st Apr 20253:15 pmRNSTotal Voting Rights
31st Mar 202511:00 amRNSHolding(s) in Company
19th Mar 202511:00 amRNSHolding(s) in Company
14th Mar 20252:15 pmRNSDirector/PDMR Shareholding
13th Mar 202512:00 pmRNSHolding(s) in Company
6th Mar 202512:00 pmRNSAdditional Listing
3rd Mar 202511:20 amRNSTotal Voting Rights
3rd Mar 20257:05 amRNSSale of Argos Store Card Portfolio
14th Feb 202511:45 amRNSDirector/PDMR Shareholding
12th Feb 202511:00 amRNSDirector/PDMR Shareholding
3rd Feb 20253:30 pmRNSBlock listing Interim Review
3rd Feb 20253:15 pmRNSTotal Voting Rights
29th Jan 202511:40 amRNSPublication of Final Terms
17th Jan 20252:40 pmRNSDirector/PDMR Shareholding
17th Jan 202511:30 amRNSPublication of a Prospectus
10th Jan 20257:00 amRNSTrading Statement
8th Jan 202510:00 amRNSHolding(s) in Company
8th Jan 202510:00 amRNSHolding(s) in Company
2nd Jan 20251:10 pmRNSTotal Voting Rights
20th Dec 20241:00 pmRNSDirector/PDMR Shareholding
19th Dec 202410:30 amRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
12th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
9th Dec 20247:00 amRNSTransaction in Own Shares
6th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 202410:05 amRNSDirector Declaration
5th Dec 20247:00 amRNSTransaction in Own Shares
4th Dec 20247:00 amRNSTransaction in Own Shares
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 202411:40 amRNSTotal Voting Rights
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20243:15 pmRNSDirector/PDMR Shareholding
22nd Nov 20247:00 amRNSCommencement of Second Tranche of Share Buyback

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.